Friday, October 30, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 21, 2026

Zacks Industry Outlook Highlights Nutrien, CF Industries and Yara

View original at nasdaq.com
Zacks Industry Outlook Highlights Nutrien, CF Industries and Yara For Immediate Release Chicago, IL – April 21, 2026 – Today, Zacks Equity Research discussesNutrien Ltd…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Strong demand and supply tightness led to an uptick in fertilizer prices in 2025, with phosphate prices seeing a notable increase

    60% confidence
  • The consensus estimate for CF's 2026 earnings has been revised 36.5% upward over the past 60 days

    60% confidence
  • Prices of phosphate, potash and nitrogen remained depressed in 2023 and 2024 amid oversupply in the market and weak demand

    60% confidence
  • Favorable farmer economics, improved affordability and low inventory levels are expected to drive potash demand globally

    60% confidence
  • The Zacks Fertilizers industry carries a Zacks Industry Rank #41, which places it in the top 17% of more than 250 Zacks industries

    60% confidence
  • In the past five years, the industry has traded as high as 18.05X and as low as 4.55X, with a median of 9.76X

    60% confidence
  • Higher prices are expected to drive top-line and margin expansion for companies in this space over the near term

    60% confidence
  • Yara has a trailing four-quarter earnings surprise of roughly 74.5%, on average

    60% confidence
  • The Zacks Fertilizers industry is poised to gain from solid demand fundamentals for key crop nutrients like phosphate and potash

    60% confidence
  • Rising natural gas prices, a key feedstock for nitrogen fertilizer, are a concern

    60% confidence
  • Supply disruptions from Russia amid the war with Ukraine contributed to the rise in prices of both sulfur and ammonia

    60% confidence
  • Nutrien is seeing strong demand in its major markets, particularly North America

    60% confidence
  • Higher fertilizer prices also augur well for these industry players

    60% confidence
  • The phosphate market is supported by low producer and channel inventories

    60% confidence
  • Nutrien has expected earnings growth of 9% for 2026

    60% confidence
  • Cost reductions and actions to strengthen the balance sheet are expected to boost Yara's profitability and cash flows

    60% confidence
  • CF Industries has an expected earnings growth rate of 6.2% for 2026

    60% confidence
  • A favorable nitrogen demand environment bodes well for Yara International

    60% confidence
  • The upward momentum in fertilizer prices continues this year (2026)

    60% confidence
  • The top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1

    60% confidence
  • Prices of both sulfur and ammonia — key inputs for the production of phosphate — remain elevated

    60% confidence
  • Nutrien is gaining from acquisitions, cost efficiency and increased adoption of its digital platform

    60% confidence
  • Expectations of high levels of planted corn and soybean acres globally suggest a pickup in fertilizer demand in 2026

    60% confidence
  • Industry participants such as Nutrien Ltd., CF Industries Holdings, Inc. and Yara International ASA are set to benefit from higher demand for fertilizers in major markets

    60% confidence
  • The Zacks Consensus Estimate for Nutrien's 2026 earnings has been revised 4.4% upward over the past 60 days

    60% confidence
  • Yara International has an expected earnings growth rate of 33.5% for 2026

    60% confidence
  • Strong agricultural market conditions and favorable farm economics are driving fertilizer demand worldwide

    60% confidence
  • The industry is currently trading at 8.76X EV/EBITDA compared with the S&P 500's 18.64X and the sector's 15.43X

    60% confidence
  • Demand for crop nutrients is being supported by the need to increase the production of grains to address rising food consumption globally

    60% confidence
  • CF is seeing higher nitrogen demand for industrial uses in North America

    60% confidence

Data points we hold from this source

S&P 500 · ev ebitda ratio18.64 multiple
S&P 500 · stock performance42.8 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com
Zacks Industry Outlook Highlights Nutrien, CF Industries and Yara — Source | Via News | Finance Via News